Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02825290|
Recruitment Status : Unknown
Verified December 2016 by Dr. Eran Zilberberg, Sheba Medical Center.
Recruitment status was: Recruiting
First Posted : July 7, 2016
Last Update Posted : December 13, 2016
|Condition or disease||Intervention/treatment||Phase|
|Embryo Transfer Luteal Support||Drug: Choriogonadotropin alfa Drug: Triptorelin acetate||Phase 4|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||62 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study|
|Study Start Date :||July 2016|
|Estimated Primary Completion Date :||June 2017|
|Estimated Study Completion Date :||June 2017|
Experimental: Study group
hCG (Choriogonadotropin alfa; Ovitrelle 250 mcg) on day of embryo transfer & GnRH-agonist (Triptorelin acetate; Decapeptyl 0.1 mg) after 4 days In addition to the usual progesterone luteal support.
Drug: Choriogonadotropin alfa
Drug: Triptorelin acetate
No Intervention: Control group
The usual progesterone only luteal phase support.
- Ongoing pregnancy [ Time Frame: About 10-12 weeks after embryo transfer ]Number of viable pregnancies at about 10-12 weeks of gestation.
- Implantation rate [ Time Frame: 2 weeks after embryo transfer ]Positive BhCG blood test
- Clinical pregnancy [ Time Frame: About 3-4 weeks after embryo transfer ]Visible intrauterine gestational sacs on ultrasound exam
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02825290
|Contact: Eran Zilberberg, MDfirstname.lastname@example.org|
|Contact: Raoul Orvieto, MD||+97235302882|
|Sheba medical center||Recruiting|
|Ramat Gan, Israel|
|Contact: Eran Zilberberg, MD +97235302882|